Oppenheim, D. E., Spreafico, R., Etuk, A., Malone, D., Amofah, E., Peña-Murillo, C., . . . Ross, P. (2014). Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy. Nature Publishing Group.
Chicago Stili AlıntıOppenheim, D E., et al. Glyco-engineered Anti-EGFR MAb Elicits ADCC By NK Cells From Colorectal Cancer Patients Irrespective of Chemotherapy. Nature Publishing Group, 2014.
MLA AlıntıOppenheim, D E., et al. Glyco-engineered Anti-EGFR MAb Elicits ADCC By NK Cells From Colorectal Cancer Patients Irrespective of Chemotherapy. Nature Publishing Group, 2014.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..